In contrast, a study investigating specific genetic variations in the IL6 promoter, including − 174 G/C and − 572 G/C polymorphisms, found associations with insulin resistance, dyslipidemia, and increased serum insulin release [79]. Here, INS is linked to metabolic syndrome.